influenza vaccine

Sanofi ships first flu vaccines for 2018-2019 season

Sanofi ships first flu vaccines for 2018-2019 season

SWIFTWATER, Pa. – Sanofi Pasteur, the vaccine division of Sanofi has shipped the first of its nearly 70 million flu vaccine doses to health care providers for the upcoming flu season. This year’s supply uses both egg-based and recombinant technologies, and includes increased production of Flublok Quadrivalent vaccine and Fluzone High-Dose vaccine, as well as continued

Sanofi’s Fluzone High-Dose approved in Canada

Sanofi’s Fluzone High-Dose approved in Canada

TORONTO — Health Canada has approved Sanofi Pasteur’s Fluzone High-Dose influenza vaccine developed for adults age 65 and older. A trivalent vaccine, Fluzone High-Dose contains four times the amount of hemagglutinin (HA) per strain versus a standard dose vaccine and is administered as a single, 0.5 ml intramuscular injection. The higher-dose flu shot, which already has

Assessing the flu vaccine

Late in 2014, we got news that the most prevalent circulating influenza virus strain this season, H3N2 (A/Switzerland/9715293/2013), was antigenically different from the H3N2 strain that was used to produce this year’s flu vaccine. Depending on the source from which one first heard this news, the sentiments ranged from the cynical — “the vaccine is